Alzamend Neuro (ALZN) Shares Outstanding (Diluted) (2020 - 2026)
Alzamend Neuro (ALZN) posted Shares Outstanding (Diluted) of 4.48 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 112.7% from 2.11 million a year earlier and up 34.2% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2026 (ended Apr 30, 2026), Alzamend Neuro's Shares Outstanding (Diluted) came in at 3.34 million, up 640.3% from FY2025.
- Annual Shares Outstanding (Diluted) has increased for four consecutive fiscal years, with a four-year compound annual growth rate of 166.7% (FY2022 to FY2026).
- In prior fiscal years, Alzamend Neuro's Shares Outstanding (Diluted) was 450,799 in FY2025 (+499.7%), 75,173 in FY2024 (+4.1%), 72,235 in FY2023 (+9.4%) and 65,999 in FY2022.
- The fiscal Q1 2027 figure stands as the highest quarterly Shares Outstanding (Diluted) in data going back to fiscal Q1 2022.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased in each of the last four quarters, with growth averaging 522.1% over the last seven quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 1.0% in fiscal Q1 2024 to 761.6% in fiscal Q2 2026.
- According to Business Quant data, Shares Outstanding (Diluted) for the three prior fiscal quarters was 3.34 million (Q4 2026), 3.8 million (Q3 2026) and 3.38 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Alzamend Neuro | 6.51 Mn | -8.95 Mn | - | 4.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 4.48 Mn |
| Apr 30, 2026 | 3.34 Mn |
| Jan 31, 2026 | 3.80 Mn |
| Oct 31, 2025 | 3.38 Mn |
| Jul 31, 2025 | 2.11 Mn |
| Apr 30, 2025 | 450,799.00 |
| Jan 31, 2025 | 613,082.00 |
| Oct 31, 2024 | 392,407.00 |
| Jul 31, 2024 | 86,424.00 |
| Apr 30, 2024 | 75,173.00 |
| Jan 31, 2024 | 78,381.00 |
| Oct 31, 2023 | 72,930.00 |
| Jul 31, 2023 | 72,918.00 |
| Apr 30, 2023 | 72,235.00 |
| Jan 31, 2023 | 72,833.00 |
| Oct 31, 2022 | 72,213.00 |
| Jul 31, 2022 | 72,212.00 |
| Apr 30, 2022 | 65,999.00 |
| Jan 31, 2022 | 69,755.00 |
| Oct 31, 2021 | 69,231.00 |
API Access
Alzamend Neuro Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();